Two Sigma Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $262K | Buy |
+4,550
| New | +$261K | 0.02% | 978 |
|
|
2025
Q4 | – | Sell |
-43,983
| Closed | -$1.98M | – | 1503 |
|
|
2025
Q3 | $1.98M | Buy |
43,983
+39,447
| +870% | +$1.84M | 0.29% | 65 |
|
|
2025
Q2 | $210K | Buy |
+4,536
| New | +$223K | 0.03% | 895 |
|
|
2024
Q4 | – | Sell |
-4,086
| Closed | -$228K | – | 1790 |
|
|
2024
Q3 | $211K | Sell |
4,086
-324,673
| -99% | -$15.2M | ﹤0.01% | 2100 |
|
|
2024
Q2 | $13.7M | Buy |
328,759
+323,458
| +6,102% | +$14.5M | 0.16% | 144 |
|
|
2024
Q1 | $287K | Sell |
5,301
-105,672
| -95% | -$5.38M | ﹤0.01% | 2000 |
|
|
2023
Q4 | $5.69M | Sell |
110,973
-212,599
| -66% | -$11.2M | 0.06% | 334 |
|
|
2023
Q3 | $18.8M | Buy |
323,572
+261,082
| +418% | +$16M | 0.2% | 101 |
|
|
2023
Q2 | $4M | Buy |
62,490
+47,695
| +322% | +$3.2M | 0.06% | 358 |
|
|
2023
Q1 | $1.03M | Buy |
14,795
+9,868
| +200% | +$696K | 0.02% | 827 |
|
|
2022
Q4 | $354K | Sell |
4,927
-3,384
| -41% | -$255K | 0.01% | 1380 |
|
|
2022
Q3 | $591K | Buy |
8,311
+4,387
| +112% | +$318K | 0.02% | 965 |
|
|
2022
Q2 | $302K | Sell |
3,924
-5,129
| -57% | -$391K | 0.01% | 1292 |
|
|
2022
Q1 | $661K | Buy |
9,053
+4,943
| +120% | +$332K | 0.02% | 832 |
|
|
2021
Q4 | $256K | Sell |
4,110
-12,866
| -76% | -$755K | 0.01% | 914 |
|
|
2021
Q3 | $1M | Buy |
16,976
+1,566
| +10% | +$103K | 0.03% | 500 |
|
|
2021
Q2 | $1.03M | Buy |
+15,410
| New | +$1M | 0.03% | 401 |
|
|
2021
Q1 | – | Sell |
-10,577
| Closed | -$658K | – | 919 |
|
|
2020
Q4 | $656K | Buy |
+10,577
| New | +$650K | 0.02% | 566 |
|
|
2020
Q3 | – | Sell |
-6,317
| Closed | -$380K | – | 1307 |
|
|
2020
Q2 | $371K | Buy |
+6,317
| New | +$378K | 0.01% | 767 |
|
|
2019
Q4 | – | Sell |
-74,023
| Closed | -$4.24M | – | 2333 |
|
|
2019
Q3 | $3.75M | Buy |
74,023
+38,990
| +111% | +$1.83M | 0.03% | 379 |
|
|
2019
Q2 | $1.59M | Buy |
35,033
+30,589
| +688% | +$1.42M | 0.02% | 543 |
|
|
2019
Q1 | $212K | Buy |
+4,444
| New | +$221K | ﹤0.01% | 1440 |
|
|
2018
Q4 | – | Sell |
-30,311
| Closed | -$1.63M | – | 2173 |
|
|
2018
Q3 | $1.88M | Sell |
30,311
-86,302
| -74% | -$5.12M | 0.01% | 746 |
|
|
2018
Q2 | $6.45M | Buy |
116,613
+75,795
| +186% | +$4.09M | 0.03% | 399 |
|
|
2018
Q1 | $2.58M | Buy |
40,818
+35,555
| +676% | +$2.29M | 0.01% | 745 |
|
|
2017
Q4 | $323K | Sell |
5,263
-1,026
| -16% | -$64.2K | 0.01% | 956 |
|
|
2017
Q3 | $401K | Buy |
+6,289
| New | +$367K | 0.04% | 309 |
|
|
2017
Q2 | – | Sell |
-9,596
| Closed | -$522K | – | 873 |
|
|
2017
Q1 | $522K | Buy |
9,596
+4,506
| +89% | +$247K | 0.1% | 185 |
|
|
2016
Q4 | $297K | Buy |
+5,090
| New | +$278K | 0.1% | 266 |
|
Other funds holding BMY
Two Sigma Securities's BMY Position: Q2 2026 in Review
Two Sigma Securities opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 4,550 shares worth $262K. The stake represents 0.02% of the portfolio and ranks #978 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in BMY as recently as Q3 2025.
Two Sigma Securities first reported a position in BMY in Q4 2016 and has held it in 29 quarters since. The position peaked at $18.8M in Q3 2023. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Two Sigma Securities held 4,550 shares of Bristol-Myers Squibb worth $262K as of Q2 2026.
- Bristol-Myers Squibb was a new Two Sigma Securities position in Q2 2026.
- Bristol-Myers Squibb made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #978 holding.
- Two Sigma Securities first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 29 quarters since.
- Two Sigma Securities's Bristol-Myers Squibb position peaked at $18.8M in Q3 2023.
- 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.